MAPK3 and neoplasm: Given that Rap2B is an upstream target of the Ca2+-related ERK1/2 signaling pathway in cancer cells, Rap2B possibly contributes to important events during tumor progression, such as cell proliferation, migration, invasion, and metastasis42, 43.